Shawn Tomasello

Board Member, Board Chair, Former CEO, Advisor, Former CCO, Biotech Innovator, Change Agent

Role: Board Member at 4D Molecular Therapeutics
Location: Santa Rosa Beach, FL, US
LinkedIn followers: 500 followers

General Business & ManagementView LinkedIn profile

Experience

Board Member
4D Molecular Therapeutics
Nov 2020 — Present · Emeryville, CA, US

Education

University of Cincinnati
BS, Marketing
1982
Murray State University
MBA, Business
1989

Skills

Pharmaceutical Industry
Life Sciences
Clinical Research
Clinical Trials
Oncology
Income Statement
Sales Effectiveness
P
Biopharmaceuticals
Oncology Clinical Research
Healthcare
Cardiology
Managed Care
Clinical Development
Market Access
Sales Operations
Commercialization
Cross-Functional Team Leadership
Biotechnology
Pharmaceutical Sales
Product Launch
Segmentation
Endocrinology

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@4dmoleculartherapeutics.com
Personal email
•••••@•••••.com
Direct dial
+18•••••••01

Unlock verified contacts

Free to start · No credit card required

Current company

4D Molecular Therapeutics

Biotechnology Research · 217 employees · Founded 2013 · Emeryville, California, United States

4DMT is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. The Company’s lead product candidate 4D-150 is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi-year sustained delivery of anti-VEGF biologics (aflibercept and anti-VEGF-C) with a single intravitreal injection, which substantially reduces the treatment burden associated with current bolus injections. The Company’s lead indication for 4D-150 is wet age-related macular degeneration, which is currently in Phase 3 development, and second indication is diabetic macular edema. The Company’s second product candidate is 4D-710, which is the first known genetic medicine to demonstrate successful delivery and expression of the CFTR transgene in the lungs of people with cystic fibrosis after aerosol delivery. We are taking genetic medicine to new heights and into new disease areas to overcome challenges not addressed by existing medicines. This incredible challenge drives our relentless and talented team. Our people are the essence of our inspiring, innovative and collaborative environment that encourages individual contributions and provides opportunities for career development. We seek the best in the industry who identify with our mission and our bold and innovative results-driven approach. Our Core Values drive the way we work together: - Dare to Cure - Break Boundaries - Beyond Yourself - Prepare & Execute Relentlessly Join us in creating the future of genetic medicine.

4dmoleculartherapeutics.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Experience

Board Member

Education

University of Cincinnati

Murray State University

Skills

Find verified contacts for anyone on LinkedIn